[August 18, 2016] |
|
World Progressive Supranuclear Palsy Pipeline Insights 2016 - Research and Markets
Research and Markets has announced the addition of the "Progressive
Supranuclear Palsy -Pipeline Insights, 2016" report to their
offering.
Progressive Supranuclear Palsy-Pipeline Insights, 2016 provides in depth
insights on the pipeline drugs and their development activities around
the Progressive Supranuclear Palsy. The report covers the product
profiles in various stages of development including Discovery,
Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Progressive
Supranuclear Palsy.
The report also assesses the Progressive Supranuclear Palsy therapeutics
by Monotherapy, Combination products, molecule type and Route of
Administration.
Scope
-
The report provides competitive pipeline landscape of Progressive
Supranuclear Palsy
li>
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Progressive Supranuclear Palsy pipeline on the basis
of target, MOA, route of administration, technology involved and
molecule type
-
The report reviews key players involved in the therapeutics
development for Progressive Supranuclear Palsy and also provide
company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information about this report visit http://www.researchandmarkets.com/research/6rtmmg/progressive
Related Topics: Central
Nervous System Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160818005500/en/
[ Back To TMCnet.com's Homepage ]
|